Abstract:Bone morphogenetic proteins (BMPs) are secreted cytokines that were initially discovered on the basis of their ability to induce bone. Several decades of research have now established that these proteins function in a large variety of physiopathological processes. There are about 15 BMP family members, which signal via three transmembrane type II receptors and four transmembrane type I receptors. Mechanistically, BMP binding leads to phosphorylation of the type I receptor by the type II receptor. This activated heteromeric complex triggers intracellular signaling that is initiated by phosphorylation of receptor‐regulated SMAD1, 5, and 8 (also termed R‐SMADs). Activated R‐SMADs form heteromeric complexes with SMAD4, which engage in specific transcriptional responses. There is convergence along the signaling pathway and, besides the canonical SMAD pathway, BMP‐receptor activation can also induce non‐SMAD signaling. Each step in the pathway is fine‐tuned by positive and negative regulation and crosstalk with other signaling pathways. For example, ligand bioavailability for the receptor can be regulated by ligand‐binding proteins that sequester the ligand from interacting with receptors. Accessory co‐receptors, also known as BMP type III receptors, lack intrinsic enzymatic activity but enhance BMP signaling by presenting ligands to receptors. In this review, we discuss the role of BMP receptor signaling and how corruption of this pathway contributes to cardiovascular and musculoskeletal diseases and cancer. We describe pharmacological tools to interrogate the function of BMP receptor signaling in specific biological processes and focus on how these agents can be used as drugs to inhibit or activate the function of the receptor, thereby normalizing dysregulated BMP signaling. © 2018 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.

Repulsive guidance molecule is a structural bridge between neogenin and bone morphogenetic protein

Repulsive Guidance Molecules (rgms) and Their Potential Implication in Cancer As Co-receptor of BMPs

Construction of a Eukaryotic Expression Vector Pegfp-C1-bmp-2 and Its Effect on Cell Migration

Repulsive guidance molecules b (RGMb): molecular mechanism, function and role in diseases

Repulsive Guidance Molecule B (rgmb) Plays Negative Roles in Breast Cancer by Coordinating Bmp Signaling

Repulsive Guidance Molecules, Novel Bone Morphogenetic Protein Co-Receptors, Are Key Regulators of the Growth and Aggressiveness of Prostate Cancer Cells

Tumour Angiogenesis and Repulsive Guidance Molecule B: a Role in HGF- and BMP-7-mediated Angiogenesis.

Roles of Bone Morphogenetic Proteins and Their Receptors in Mammalian Reproduction

Secreted BMP Antagonists and Their Role in Cancer and Bone Metastases.

Potential Prognostic Value of Repulsive Guidance Molecules in Breast Cancer.

Structural insights into the formation of repulsive netrin guidance complexes

N-linked glycosylation of the bone morphogenetic protein receptor type 2 (BMPR2) enhances ligand binding

Bone Morphogenetic Protein Receptor Signal Transduction in Human Disease

BMP2-mimicking Peptide Modified with E7 Coupling to Calcined Bovine Bone Enhanced Bone Regeneration Associating with Activation of the Runx2/SP7 Signaling Axis.

Bone Morphogenetic Proteins In The Initiation And Progression Of Breast Cancer

Bone Morphogenetic Protein Receptors: Structure, Function and Targeting by Selective Small Molecule Kinase Inhibitors

Ret is a Multifunctional Coreceptor That Integrates Diffusible- and Contact-Axon Guidance Signals.

Identification of a Key Residue Mediating Bone Morphogenetic Protein (BMP)-6 Resistance to Noggin Inhibition Allows for Engineered BMPs with Superior Agonist Activity

The BMP antagonist Noggin promotes cranial and spinal neurulation by distinct mechanisms

FRET reveals novel protein-receptor interaction of bone morphogenetic proteins receptors and adaptor protein 2 at the cell surface

Controlling Cell Fate By Bone Morphogenetic Protein Receptors